Health
Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection – News-Medical.Net
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing…
Reviewed by Emily Henderson, B.Sc.Sep 2 2020
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.
Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and…
-
Noosa News17 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General17 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General6 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania